fda on compounded semaglutide issues warning about some versions of for diabetes, weight loss FDA Ban on Compounded GLP-1

Please ensure you select the correct option before checkout

Frequently asked questions What is retatrutide?+ Retatrutide is a synthetic peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors, studied in metabolic research as a next-generation incretin compound

Any weight loss program should begin with a thorough medical evaluation, and this applies regardless of which platform you choose

[15] Therefore, achieving and maintaining a healthy weight through appropriate interventions, potentially including GLP-1 medicines when indicated, may offer overall health benefits that need to be weighed against any theoretical risks

Are GLP-1 side effects different if you don't have diabetes

iScience 2021, 24